Endpoint definition
↥| Name | VWXY20_DRUGS_MEDICAM_BIOLO_SUBST_CAUSI_ADVER_EFFEC_THERAPE_USE |
|---|---|
| Long name | Drugs, medicaments and biological substances causing adverse effects in therapeutic use |
| Level in the ICD-hierarchy | 3 |
| First defined in version | DF4 |
Drugs, medicaments and biological substances causing adverse effects in therapeutic use
No definition available.
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 18 | 11 | 7 |
| Unadjusted prevalence (%) | 0.01 | 0.01 | 0.01 |
| Mean age at first event (years) | 61.94 | 63.07 | 60.17 |
| Case fatality at 5-years (%) | 50.00 | 45.45 | 57.14 |
Longitudinal metrics
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 1.0 | 1.0 | 1.0 |
| Recurrence at 6 months (%) | - | - | - |
Survival analyses between endpoints
↥Plot
before Drugs, medicaments and biological substances causing adverse effects in therapeutic use
after Drugs, medicaments and biological substances causing adverse effects in therapeutic use
Loading survival analyses plot…
Table
Loading survival analyses table…